137 related articles for article (PubMed ID: 1630603)
21. In situ hybridization studies on mRNAs for cholecystokinin, calcitonin gene-related peptide and choline acetyltransferase in the lower brain stem, spinal cord and dorsal root ganglia of rat and guinea pig with special reference to motoneurons.
Cortés R; Arvidsson U; Schalling M; Ceccatelli S; Hökfelt T
J Chem Neuroanat; 1990; 3(6):467-85. PubMed ID: 2291815
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat.
Xu XJ; Puke MJ; Verge VM; Wiesenfeld-Hallin Z; Hughes J; Hökfelt T
Neurosci Lett; 1993 Apr; 152(1-2):129-32. PubMed ID: 8515864
[TBL] [Abstract][Full Text] [Related]
23. Altered cholecystokinin binding site density in the supraoptic nucleus of morphine-tolerant and -dependent rats.
Munro G; Pumford KM; Russell JA
Brain Res; 1998 Jan; 780(2):190-8. PubMed ID: 9507122
[TBL] [Abstract][Full Text] [Related]
24. Developmental and regional changes of cholecystokinin mRNA in rat brains.
Hasegawa M; Usui H; Araki K; Kuwano R; Takahashi Y
FEBS Lett; 1986 Jan; 194(2):224-6. PubMed ID: 3940896
[TBL] [Abstract][Full Text] [Related]
25. Morphine-induced in vivo release of spinal cholecystokinin is mediated by delta-opioid receptors--effect of peripheral axotomy.
Gustafsson H; Afrah AW; Stiller CO
J Neurochem; 2001 Jul; 78(1):55-63. PubMed ID: 11432973
[TBL] [Abstract][Full Text] [Related]
26. Regional distribution of calcitonin gene-related peptide-, substance P-, cholecystokinin-, Met5-enkephalin-, and dynorphin A (1-8)-like materials in the spinal cord and dorsal root ganglia of adult rats: effects of dorsal rhizotomy and neonatal capsaicin.
Pohl M; Benoliel JJ; Bourgoin S; Lombard MC; Mauborgne A; Taquet H; Carayon A; Besson JM; Cesselin F; Hamon M
J Neurochem; 1990 Oct; 55(4):1122-30. PubMed ID: 1697886
[TBL] [Abstract][Full Text] [Related]
27. Effect of a single injection of psychoactive drugs on CCK mRNA in rat brain.
Yoshikawa T; Kunishima C; Yamada K; Nabeshima T; Shibuya H; Toru M
Peptides; 1994; 15(3):471-3. PubMed ID: 7937322
[TBL] [Abstract][Full Text] [Related]
28. Rapid but transient increases in cholecystokinin mRNA levels in cerebral cortex following amygdaloid-kindled seizures in the rat.
Burazin TC; Gundlach AL
Neurosci Lett; 1996 May; 209(1):65-8. PubMed ID: 8734911
[TBL] [Abstract][Full Text] [Related]
29. Effect of pentylenetetrazol treatment on cholecystokinin mRNA and peptide levels in rat hippocampus and cortex.
Takeda K; Nakata K; Takahashi S; Chikuma T; Kato T
Brain Res; 1998 Jan; 779(1-2):320-3. PubMed ID: 9473710
[TBL] [Abstract][Full Text] [Related]
30. Neuronal localization of cholecystokinin mRNA in the rat brain by using in situ hybridization histochemistry.
Ingram SM; Krause RG; Baldino F; Skeen LC; Lewis ME
J Comp Neurol; 1989 Sep; 287(2):260-72. PubMed ID: 2794128
[TBL] [Abstract][Full Text] [Related]
31. Intrathecal cholecystokinin interacts with morphine but not substance P in modulating the nociceptive flexion reflex in the rat.
Wiesenfeld-Hallin Z; Duranti R
Peptides; 1987; 8(1):153-8. PubMed ID: 2437547
[TBL] [Abstract][Full Text] [Related]
32. Cholecystokinin in the rat spinal cord: distribution and lack of effect of neonatal capsaicin treatment and rhizotomy.
Marley PD; Nagy JI; Emson PC; Rehfeld JF
Brain Res; 1982 Apr; 238(2):494-8. PubMed ID: 7093671
[TBL] [Abstract][Full Text] [Related]
33. Cholecystokinin in mammalian primary sensory neurons and spinal cord: in situ hybridization studies in rat and monkey.
Verge VM; Wiesenfeld-Hallin Z; Hökfelt T
Eur J Neurosci; 1993 Mar; 5(3):240-50. PubMed ID: 8261105
[TBL] [Abstract][Full Text] [Related]
34. Activation of oxytocin neurones by systemic cholecystokinin is unchanged by morphine dependence or withdrawal excitation in the rat.
Brown CH; Munro G; Murphy NP; Leng G; Russell JA
J Physiol; 1996 Nov; 496 ( Pt 3)(Pt 3):787-94. PubMed ID: 8930844
[TBL] [Abstract][Full Text] [Related]
35. Alteration in the brain content of substance P (1-7) during withdrawal in morphine-dependent rats.
Zhou Q; Liu Z; Ray A; Huang W; Karlsson K; Nyberg F
Neuropharmacology; 1998 Dec; 37(12):1545-52. PubMed ID: 9886677
[TBL] [Abstract][Full Text] [Related]
36. Differential inhibitory/stimulatory modulation of spinal CCK release by mu and delta opioid agonists, and selective blockade of mu-dependent inhibition by kappa receptor stimulation.
Benoliel JJ; Bourgoin S; Mauborgne A; Legrand JC; Hamon M; Cesselin F
Neurosci Lett; 1991 Apr; 124(2):204-7. PubMed ID: 1648690
[TBL] [Abstract][Full Text] [Related]
37. Postnatal development of cholecystokinin-like immunoreactivity and its mRNA level in rat brain regions.
Takeda K; Koshimoto H; Uchiumi F; Haun RS; Dixon JE; Kato T
J Neurochem; 1989 Sep; 53(3):772-8. PubMed ID: 2760620
[TBL] [Abstract][Full Text] [Related]
38. Changes in CCK mRNA in hippocampal neurones following fimbria fornix transection.
Panni MK; Wilson VJ; Capoor U; Sofroniew MV; Rattray M
Neuroreport; 1994 Jun; 5(11):1377-80. PubMed ID: 7919204
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of precipitated withdrawal from spinal morphine: changes in [Met5]enkephalin levels.
Cridland RA; Sutak M; Jhamandas K
Eur J Pharmacol; 1991 Oct; 203(1):93-103. PubMed ID: 1797559
[TBL] [Abstract][Full Text] [Related]
40. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study.
Monstein HJ; Nylander AG; Salehi A; Chen D; Lundquist I; Håkanson R
Scand J Gastroenterol; 1996 Apr; 31(4):383-90. PubMed ID: 8726308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
